Follow
Henrik Gregersen
Henrik Gregersen
Unknown affiliation
Verified email at rn.dk
Title
Cited by
Cited by
Year
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype
KE Smedby, H Hjalgrim, J Askling, ET Chang, H Gregersen, ...
Journal of the National Cancer Institute 98 (1), 51-60, 2006
4962006
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M‐proteins and the management of monoclonal gammopathy of …
J Bird, J Behrens, J Westin, I Turesson, M Drayson, R Beetham, S D’Sa, ...
British journal of haematology 147 (1), 22-42, 2009
1892009
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
UH Mellqvist, P Gimsing, O Hjertner, S Lenhoff, E Laane, K Remes, ...
Blood, The Journal of the American Society of Hematology 121 (23), 4647-4654, 2013
1762013
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network
NWCJ van de Donk, A Palumbo, HE Johnsen, M Engelhardt, F Gay, ...
haematologica 99 (6), 984, 2014
1652014
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised …
P Gimsing, K Carlson, I Turesson, P Fayers, A Waage, A Vangsted, ...
The lancet oncology 11 (10), 973-982, 2010
1342010
The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance
H Gregersen, L Mellemkjær, JS Ibsen, JF Dahlerup, L Thomassen, ...
Haematologica 86 (11), 1172-1179, 2001
902001
Third generation oral contraceptives and heritable thrombophilia as risk factors of non-fatal venous thromboembolism
BS Andersen, J Olsen, GL Nielsen, FH Steffensen, HT Sørensen, J Baech, ...
Thrombosis and haemostasis 59 (01), 28-31, 1998
811998
Smoldering multiple myeloma risk factors for progression: a Danish population‐based cohort study
R Sørrig, TW Klausen, M Salomo, AJ Vangsted, B Østergaard, ...
European journal of haematology 97 (3), 303-309, 2016
672016
The data quality of haematological malignancy ICD-10 diagnoses in a population-based hospital discharge registry
M Nørgaard, MV Skriver, H Gregersen, G Pedersen, HC Schønheyder, ...
European journal of cancer prevention 14 (3), 201-206, 2005
672005
Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance
H Gregersen, JS Ibsen, L Mellemkjœr, JF Dahlerup, JH Olsen, ...
British journal of haematology 112 (2), 353-357, 2001
672001
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma …
MO Holmström, P Gimsing, N Abildgaard, NF Andersen, C Helleberg, ...
American journal of hematology 90 (4), E73-4, 2015
592015
The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance
H Gregersen, KM Madsen, HT Sørensen, HC Schønheyder, JS Ibsen, ...
European journal of haematology 61 (2), 140-144, 1998
581998
Fracture risk in patients with monoclonal gammopathy of undetermined significance
H Gregersen, P Jensen, M Gislum, B Jørgensen, HT Sørensen, ...
British journal of haematology 135 (1), 62-67, 2006
562006
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study
H Gregersen, AJ Vangsted, N Abildgaard, NF Andersen, RS Pedersen, ...
Cancer medicine 6 (7), 1807-1816, 2017
542017
Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism
H Gregersen, M Nørgaard, MT Severinsen, MC Engebjerg, P Jensen, ...
European journal of haematology 86 (2), 129-134, 2011
452011
Cancer risk in patients with monoclonal gammopathy of undetermined significance
H Gregersen, L Mellemkjær, J Salling Ibsen, HT Sørensen, JH Olsen, ...
American journal of hematology 63 (1), 1-6, 2000
452000
The Danish national multiple myeloma registry
P Gimsing, MO Holmström, TW Klausen, NF Andersen, H Gregersen, ...
Clinical epidemiology, 583-587, 2016
432016
The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT
AJ Vangsted, TW Klausen, W Ruminski, P Gimsing, NF Andersen, ...
Bone Marrow Transplantation 43 (7), 539-545, 2009
432009
Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma
NF Andersen, U Vogel, TW Klausen, P Gimsing, H Gregersen, ...
International Journal of Cancer 131 (5), E636-E642, 2012
392012
Multiple myeloma following an episode of community acquired pneumococcal bacteraemia or meningitis
H GREGERSEN, G PEDERSEN, N SVENDSEN, AM Thulstrup, ...
Apmis 109 (11), 797-800, 2001
392001
The system can't perform the operation now. Try again later.
Articles 1–20